June 11, 2015
Shareholders of Dutch biotech outfit Prosensa Holding NV urged a New York federal judge Thursday to trigger a reconsideration of their securities class action's dismissal in order to "prevent manifest injustice" to those who lost money when the company's stock dropped following a devastating clinical-trial failure.
May 06, 2015
A New York federal judge has dismissed a shareholder class action against Dutch biotech company Prosensa Holding NV over a stock drop following a clinical-trial failure for its crown-jewel drug, saying Tuesday the plaintiffs didn't plead that executives omitted necessary information.